Patents by Inventor Suresh Kumar Swaminathan

Suresh Kumar Swaminathan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MATERIALS AND METHODS OF IL-1BETA BINDING PROTEINS
    Publication number: 20230227545
    Abstract: Provided herein, in certain aspects, are antibodies that bind to IL-1? and compositions comprising the antibodies. Methods of making and using the antibodies are also provided.
    Type: Application
    Filed: January 6, 2023
    Publication date: July 20, 2023
    Applicant: JOHNSON & JOHNSON ENTERPRISE INNOVATION INC.
    Inventors: Gabriel PASCUAL, Sagit HINDI, Suresh Kumar SWAMINATHAN
  • SINGLE-CHAIN VARIABLE FRAGMENT ANTI-CD133 ANTIBODIES AND USES THEREOF
    Publication number: 20170240627
    Abstract: Disclosed herein are a monoclonal antibody that specifically binds to human CD133 and single-chain variable fragments thereof. Also disclosed herein is a hybridoma that produces the monoclonal antibody that specifically binds to human CD133.
    Type: Application
    Filed: March 10, 2017
    Publication date: August 24, 2017
    Inventors: John R. Ohlfest, Jayanth Panyam, Suresh Kumar Swaminathan, Daniel A. Vallera
  • Single-chain variable fragment anti-CD133 antibodies and uses thereof
    Patent number: 9624303
    Abstract: Disclosed herein are a monoclonal antibody that specifically binds to human CD133 and single-chain variable fragments thereof. Also disclosed herein is a hybridoma that produces the monoclonal antibody that specifically binds to human CD133.
    Type: Grant
    Filed: January 7, 2016
    Date of Patent: April 18, 2017
    Assignee: Regents of the University of Minnesota
    Inventors: John R. Ohlfest, Jayanth Panyam, Suresh Kumar Swaminathan, Daniel A. Vallera
  • SINGLE-CHAIN VARIABLE FRAGMENT ANTI-CD133 ANTIBODIES AND USES THEREOF
    Publication number: 20160215058
    Abstract: Disclosed herein are a monoclonal antibody that specifically binds to human CD133 and single-chain variable fragments thereof. Also disclosed herein is a hybridoma that produces the monoclonal antibody that specifically binds to human CD133.
    Type: Application
    Filed: January 7, 2016
    Publication date: July 28, 2016
    Inventors: John R. Ohlfest, Jayanth Panyam, Suresh Kumar Swaminathan, Daniel A. Vallera
  • Single chain variable fragment anti-CD133 antibodies and uses thereof
    Patent number: 9249225
    Abstract: Disclosed herein are a monoclonal antibody that specifically binds to human CD 133 and single-chain variable fragments thereof. Also disclosed herein is a hybridoma that produces the monoclonal antibody that specifically binds to human CD133.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: February 2, 2016
    Assignee: Regents of the University of Minnesota
    Inventors: John R. Ohlfest, Karen Himmel Ohlfest, Jayanth Panyam, Suresh Kumar Swaminathan, Daniel A. Vallera